In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK ...

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...

Dr. Christopher Ellington, a thoracic surgeon at Ascension Sacred Heart, is the only doctor in the Pensacola area performing ...

Lung cancer is no longer solely a smoker's disease, with air pollution emerging as a significant risk factor affecting ...

DAME Esther Rantzen has shared a heartbreaking health update after stopping treatment for lung cancer. The veteran TV star, ...